We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.52%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$19.9B
AUM Growth
+$1.78B
(+9.8%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.12%
Top 10 Holdings %
Top 10 Hldgs %
51.12%
Holding
1,437
New
68
Increased
159
Reduced
493
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$473M |
| 2 |
GoDaddy
GDDY
|
+$139M |
| 3 |
McDonald's
MCD
|
+$41.2M |
| 4 |
UnitedHealth
UNH
|
+$30.4M |
| 5 |
Fidelity National Information Services
FIS
|
+$25.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$67.2M |
| 2 |
Union Pacific
UNP
|
+$54.6M |
| 3 |
Arrowhead Research
ARWR
|
+$47.4M |
| 4 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
+$32.5M |
| 5 |
Genworth Financial
GNW
|
+$24.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 41.72% |
| 2 | Technology | 13.57% |
| 3 | Healthcare | 9.87% |
| 4 | Consumer Discretionary | 8.45% |
| 5 | Communication Services | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZN
426
DELISTED
Horizon Global Corporation
HZN
| $848K | ﹤0.01% |
243,177
-51,159
| -17% | -$189K |
|
427
L3Harris
LHX
$55.9B
| $842K | ﹤0.01% |
4,260
+330
| +8% | +$66.2K |
|
428
Tootsie Roll Industries
TR
$2.82B
| $828K | ﹤0.01% |
29,849
| – | – |
|
429
Arrow Electronics
ARW
$10.9B
| $819K | ﹤0.01% |
9,676
| – | – |
|
430
Phillips 66
PSX
$82.9B
| $818K | ﹤0.01% |
7,342
-103
| -1% | -$11.6K |
|
431
Ark Restaurants
ARKR
| $808K | ﹤0.01% |
35,950
| – | – |
|
432
Vanguard Dividend Appreciation ETF
VIG
$111B
| $804K | ﹤0.01% |
6,454
-1
| -0% | -$121 |
|
433
Targa Resources
TRGP
$60.4B
| $801K | ﹤0.01% |
19,622
-90
| -0.5% | -$3.49K |
|
434
BP
BP
$113B
| $793K | ﹤0.01% |
21,036
-2,133
| -9% | -$81K |
|
435
Home BancShares
HOMB
$6.21B
| $792K | ﹤0.01% |
40,290
| – | – |
|
436
C&F Financial
CFFI
$254M
| $790K | ﹤0.01% |
14,295
| – | – |
|
437
Akebia Therapeutics
AKBA
$327M
| $783K | ﹤0.01% |
123,900
| – | – |
|
|
QVCGA
438
DELISTED
QVC Group Inc Series A
QVCGA
| $783K | ﹤0.01% |
1,914
-288
| -13% | -$130K |
|
|
MDC
439
DELISTED
M.D.C. Holdings, Inc.
MDC
| $780K | ﹤0.01% |
22,087
-1,123
| -5% | -$42.3K |
|
|
SASR
440
DELISTED
Sandy Spring Bancorp Inc
SASR
| $778K | ﹤0.01% |
20,546
-1,477
| -7% | -$52.1K |
|
|
FOMX
441
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $771K | ﹤0.01% |
231,800
-177,700
| -43% | -$565K |
|
442
Elanco Animal Health
ELAN
$12.4B
| $760K | ﹤0.01% |
25,840
-733
| -3% | -$19.9K |
|
443
Martin Marietta Materials
MLM
$33.6B
| $760K | ﹤0.01% |
2,718
-50,823
| -95% | -$13.6M |
|
444
Triumph Financial Inc
TFIN
$1.83B
| $760K | ﹤0.01% |
20,000
| – | – |
|
445
Duke Energy
DUK
$102B
| $758K | ﹤0.01% |
8,318
-24
| -0.3% | -$2.2K |
|
446
Amphenol
APH
$188B
| $757K | ﹤0.01% |
28,000
| – | – |
|
447
First Bank
FRBA
$451M
| $753K | ﹤0.01% |
68,207
| – | – |
|
|
CET
448
Central Securities Corp
CET
$1.54B
| $737K | ﹤0.01% |
22,287
+668
| +3% | +$21.5K |
|
449
Alcon
ALC
$33.1B
| $724K | ﹤0.01% |
12,803
-263
| -2% | -$15.1K |
|
450
WEX
WEX
$6.11B
| $712K | ﹤0.01% |
3,400
| – | – |
|
Similar funds
SAM
First Manhattan's Q4 2019 Portfolio in Review
As of Q4 2019, First Manhattan held 1,437 positions worth $19.9B, up 9.8% from $18.2B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
First Manhattan's Q4 2019 filing shows 68 new, 159 increased, 493 reduced and 84 closed positions. Its largest new stake was Pinduoduo: 400,000 shares worth $15.1M. The largest sale was People Inc, an estimated $67.2M.
By sector, the portfolio is most concentrated in Financials at 42% of assets, up from 40% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q4 2019 buy was Pinduoduo: 400,000 shares worth $15.1M.
- First Manhattan added most to Berkshire Hathaway Class A in Q4 2019, an estimated $473M increase.
- First Manhattan's biggest Q4 2019 reduction was People Inc, cutting an estimated $67.2M.
- First Manhattan fully exited Ra Pharmaceuticals, Inc. Common Stock in Q4 2019, selling an estimated $32.5M.
- First Manhattan's ten largest holdings make up 51% of its $19.9B portfolio in Q4 2019.
- First Manhattan opened 68 new positions and closed 84 in Q4 2019.
- First Manhattan's portfolio value rose 9.8% quarter-over-quarter to $19.9B.
Based on First Manhattan's 13F filing for Q4 2019, filed 13 Feb 2020.